Hainan Shuangcheng Pharmaceuticals: Announcement of Hainan Shuangcheng Pharmaceutical Co., Ltd. on the US FDA approval for octreotide acetate injection ANDA

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.